Methicillin-Resistant Staphylococcus Aureus Prevalence and Antibiotic Resistance

Strategic Insights -

Researchers from King Saud University conducted a seven-year study to investigate the prevalence and genetic basis of antibiotic resistance in methicillin-resistant Staphylococcus aureus (MRSA) isolates from sickle cell disease (SCD) patients in Riyadh, Saudi Arabia. The study found that 0.9% of SCD patients exhibited MRSA bloodstream infections, primarily affecting individuals over 20 years of age. The researchers analyzed 34 MRSA isolates from 3,979 SCD patients and identified a significant correlation between variations in the tetK gene and differential susceptibility to antibiotics like erythromycin, clindamycin, and ciprofloxacin.

Key Takeaways:

  • The study found that 0.9% of SCD patients in Riyadh, Saudi Arabia exhibited MRSA bloodstream infections, predominantly affecting individuals over 20 years of age.
  • The researchers analyzed 34 MRSA isolates from 3,979 SCD patients and identified a significant correlation between variations in the tetK gene and differential susceptibility to antibiotics like erythromycin, clindamycin, and ciprofloxacin.
  • The study highlights the genetic diversity of the tetK gene in MRSA strains and its function in mediating antibiotic resistance.
  • The findings suggest the need for continuous monitoring and the development of tailored treatment plans, especially for high-risk groups like patients with sickle cell disease (SCD).
  • The study also identified the toxin genes (hlg, hla, Pvl, and sea) as predominant in the MRSA isolates.
  • The researchers performed sequencing of tetK, ermA, ermC, and 16S rRNA genes and analyzed variations using bioinformatics tools.
  • Phylogenetic analysis grouped Riyadh strains into distinct clusters and correlated with phenotypic resistance profiles.
  • Although vancomycin and tobramycin are still effective treatments, resistance to other antibiotics shows the need for continuous monitoring and the development of tailored treatment plans.

Statistics:

  • 0.9% of SCD patients in Riyadh, Saudi Arabia exhibited MRSA bloodstream infections.
  • 34 MRSA isolates were analyzed from 3,979 SCD patients.
  • The study found a significant correlation between variations in the tetK gene and differential susceptibility to antibiotics like erythromycin, clindamycin, and ciprofloxacin (64.7% of isolates exhibited the toxin genes hlg, hla, Pvl, and sea).
  • All isolates were resistant to b-lactam antibiotics but sensitive to vancomycin and tobramycin.

Sources:

  • Prevalence, toxin virulence genes and investigating the effect of mutations in the tetracycline gene (tetK) on the response of methicillin-resistant Staphylococcus aureus to antibiotics: a study in sickle cell disease patients in Riyadh, Saudi Arabia. Saudi Pharmaceutical Journal, 2025,33(5):1-16.
  • https://doi-org.sdpl.idm.oclc.org/10.1007/s44446-025-00033-3
  • http://www.journals.elsevier.com/saudi-pharmaceutical-journal/ (Saudi Pharmaceutical Journal)